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ABSTRACT 
 
Early life adversity is associated with increased risk of high psychiatric disease, suicidal 
behavior as well as risky sexual behavior in adulthood. Altered functioning of several 
neurobiological systems, like the serotonergic system and the hypothalamic-pituitary-adrenal 
axis associated with suicidal behavior, may stem from both genetic and developmental 
causes. Adversity in early life has developmental effects on these systems that persist into 
adulthood. Other neuroendocrine systems such as oxytocin regulating social behavior and 
DHEA-S with multiple biological actions might also be implicated in suicidal behavior. 
Hypersexual disorder includes features of impulsivity, addiction, sexual desire deregulation 
and some aspects of hypersexual behavior are also associated with more suicidality. 
Neurobiological alterations in patients with hypersexual disorder are for the moment largely 
unknown. 
The aim of this PhD project was to investigate neuroendocrine systems with focus on HPA 
axis, Oxytocin and DHEAS in suicide attempters and in patients with Hypersexual Disorder. 
Focus was on early life adversity and violent behavior in relation to neuroendocrine 
biomarkers. 
Studies I-III:  The clinical cohort consists of 28 medication free suicide attempters and 19 
healthy volunteers who participated in this cross sectional and longitudinal study. CSF and 
plasma basal levels of oxytocin, cortisol, DHEA-S and CSF 5-HIAA levels were assessed. 
Suicide intent, depressive symptoms, interpersonal violence in childhood an adult life as well 
as childhood emotional climate were assessed with psychometric rating scales. All patients 
were followed up for cause of death.  
Results: Suicide attempters showed a trend for lower CSF oxytocin levels compared to 
healthy volunteers, CSF and plasma oxytocin was significantly negatively related to suicide 
intent especially in men and showed a trend for negative correlation with lifetime violent 
behavior. Revictimized suicide attempters had lower plasma oxytocin and a more negative 
childhood emotional climate compared to non revictimized suicide attempters. 
Higher CSF and plasma cortisol levels were also present in suicide attempters compared to 
healthy volunteers, whereas CSF DHEA-S levels were higher in male suicide attempters and 
CSF 5-HIAA levels lower in female suicide attempters respectively. CSF cortisol/DHEAS 
ratio was inversely correlated with exposure to interpersonal violence as a child adjusted for 
age, gender and depression severity in a regression analysis.  
In suicide prediction, suicide victims tended to have low CSF 5-HIAA and high CSF cortisol 
and suicide victims that were abused in childhood had higher CSF cortisol compared to 
suicide victims with low exposure to interpersonal violence as a child. Oxytocin or DHEA-S 
levels did not differ in suicide victims compared to survivors. 
Study IV: The study includes 67 male patients with hypersexual disorder and 39 healthy 
male volunteers. Basal morning plasma levels of cortisol and ACTH were assessed and the 
dexamethasone (0.5 mg) suppression test was performed with cortisol and ACTH measured 
post dexamethasone administration. Multiple psychometric rating scales were used for 
assessing sexual behavior, depressive symptoms and early life adversity. 
Results: Men with hypersexual disorder had higher DST-ACTH levels and were more often 
DST non-suppressors compared to healthy volunteers. Men with hypersexual disorder 
reported more depressive symptoms and early life adversity than healthy volunteers. Early 
life adversity and hypersexual behavior were negatively correlated with HPA axis measures 
in patients. In the regression analyses the diagnosis of hypersexual disorder was significantly 
associated with both DST non-suppression and higher plasma DST-ACTH even when 
adjusted for childhood trauma. 
Conclusion: Early life adversity, interpersonal violence and suicide intent are risk factors 
for suicide and oxytocin by modulating prosocial behaviors might thus be protective in 
individuals with high suicide risk. The role of DHEA-S in suicidal behavior is proposed to be 
through the effects of early life adversity and its implication to the allostatic load while other 
possible mechanisms cannot be excluded. The study on male patients with hypersexual 
disorder reports for the first time HPA axis dysregulation. 
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1 INTRODUCTION 
1.1 SUICIDAL BEHAVIOR 
 
Suicide is defined as the fatal result of a self-injurious act of which there is some evidence of 
the intent to die and a suicide attempt is the behavior that is considered potentially self-
injurious with at least some intent to die (Turecki and Brent, 2015). Completed suicides as 
well as suicide attempts are a major health problem with World Health Organization (WHO) 
reporting that there are more than 800 000 suicide victims every year and suicide is the 
second leading cause of death in young people age 15-29.  Consequently, suicide became a 
priority in the WHO Mental Health Action Plan 2013-2020 aiming at a 10% decrease in the 
rate of suicide by 2020. 
1.2 RISK FACTORS AND BIOMARKERS FOR SUICIDE 
As suicide is a major health problem there has been a need to identify both risk factors as 
well as biomarkers. The ultimate goal is to identify the individuals at risk so that prevention 
can take place as well as to be able to give the proper treatment to suicide attempters. A 
previous suicide attempt is the most important risk factor for a completed suicide in the future 
(Turecki and Brent, 2015). In that aim research has revealed a number of risk factors for 
suicide.  
These contributing factors to suicide can be better understood in the stress-diathesis model for 
suicidal behavior (Mann, 2003; van Heeringen and Mann, 2014). This model gives the 
possibility to illustrate the relationship between different biological systems with clinical 
correlates of suicide behavior (Mann, 2003; van Heeringen and Mann, 2014).  
The different risk factors can be categorized into three groups (Turecki and Brent, 2015). 
First, the distal factors contributing to the predisposition, including a family history of 
suicide, childhood adversity and the genetic background of the individual. The interaction 
between the genetic background and the environment in the form of stressful life events is 
known (Caspi et al., 2003). Secondly, there are developmental factors that mediate the effect 
of the distal factors to suicidal behavior. These are mainly personality traits as well as 
cognitive styles. Aggression, impulsivity, anxiety traits and deficits in decision making and 
problem solving are some mediating factors of importance (Hawton and van Heeringen, 
2009; Turecki, 2014; Turecki and Brent, 2015). Finally, the proximal factors are responsible 
for triggering suicidal behavior. Studies of psychological autopsies highlight the importance 
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of psychopathology with more than 90% of suicide victims diagnosed with a psychiatric 
illness. Most commonly depression but also psychosis, alcohol and substance abuse as well 
as borderline personality disorder. The exposure to acute stress due to recent life events such 
as a psychosocial crisis, the availability of means to commit suicide, isolation and lack of 
social support may trigger the suicidal behavior (Turecki and Brent, 2015).  
In Figure 1 the Stress Diathesis model of suicidal behavior.  
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1.2.1 Hypothalamic-Pituitary –Adrenal (HPA axis) and Serotonin  
 
There has been extensive research on different biological systems that are thought to be 
involved in suicidal behavior (Mann, 2003; Oquendo et al., 2014; Turecki, 2014). The focus 
has been on the hypothalamic– pituitary–adrenal (HPA) axis as well as the monoamines, 
noradrenergic, dopaminergic and most importantly the serotonergic system.  
The HPA axis is the central system of stress regulation that together with other 
neurobiological systems are responsible for homeostasis. Briefly, at the presence of a stressor, 
the corticotropin-releasing hormone (CRH) is released from the paraventricular nucleus of the 
hypothalamus. This subsequently triggers the secretion of adrenocorticotropic hormone 
(ACTH) from the pituitary gland. As a result glucocorticoids are produced by the adrenal 
cortex. The glucocorticoids have the ability to regulate the secretion of ACTH and CRH 
through inhibitory loops to achieve homeostasis. Glucocorticoids act by binding to the 
glucocorticoid receptor (GR) and the mineralocorticoid receptor (MR) that are scattered in 
different areas in the brain, including the hypothalamus and prefrontal cortex and regulate 
metabolism, the immune system as well as cognition (De Bellis and Zisk, 2014).  
The dexamethasone suppression test (DST) has been used to test the function of the HPA axis 
(Carroll et al., 1968). In order to test the inhibition induced to cortisol production, a synthetic 
glucocorticoid, dexamethasone, is given. If the production of cortisol is not suppressed, as 
one would expect, then the individual is characterized as non-suppressor indicating a 
dysfunction of the HPA axis. The test has been broadly used in psychiatric research (Sher, 
2006). According to a review by Coryell, completed suicide is associated with higher rates of 
DST non-suppressors, i.e., hyperactivity of the HPA axis (Coryell, 2012; Coryell and 
Schlesser, 2001; Jokinen et al., 2007; Jokinen et al., 2009). However, some other studies 
suggest a hypofunction of the HPA axis with Pfenning et al. (2005) reporting a lower 
adrenocorticotropin and cortisol response in the combined Dex/CRH test, especially in 
depressed patients with suicidal behavior (Pfennig et al., 2005) .The HPA dysfunction has 
also been shown with increased CRH in the cerebrospinal fluid of suicide victims and with 
reduced sites in the frontal cortex for the binding of CRF in suicide victims (Arato et al., 
1989; Nemeroff et al., 1988). 
The other most profound/replicated neurobiological correlate of suicidal behavior has been 
with the hypofunction of the serotonin system, indicated by lower levels of 5-hydroxyindole 
acetic acid (5-HIAA), the main metabolite of serotonin, in the cerebrospinal fluid (Asberg et 
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al., 1976; Mann and Currier, 2010; Oquendo et al., 2014; van Heeringen and Mann, 2014). It 
is proposed that there is a deficiency in the transmission of serotonin and that changes 
reported in the literature such as increased number of serotonin binding sites in the ventral 
prefrontal cortex may indicate an attempt to compensate this deficiency (Arango et al., 1995; 
van Heeringen and Mann, 2014). Besides serotonins effect on depression, the impact of this 
hypofunction of the serotonergic system on behavior is suggested as trait like aggression and 
impulsivity with impairment in inhibition that contributes to the vulnerability to committing 
suicide (Rosell and Siever, 2015; Turecki, 2014).  
At the moment although the DST non-suppression may be seen as a long-term biologic 
predictor of suicide risk is some populations (Coryell and Schlesser, 2001; Jokinen et al., 
2007; Jokinen et al., 2009; Jokinen and Nordstrom, 2008), the positive predictive value of the 
models used for prediction is still not acceptable. As suicide is a rather rare outcome, the 
construction of the prediction model is very important. Mann et al., in a prediction model for 
lethal outcome in suicide including both DST non suppression as well as low 5-HIAA 
showed a positive predictive value of 23% with 88% specificity and sensitivity 37.5%. 
Whereas, when either DST non suppression or low 5-HIAA were used in the model the 
positive predictive value was only 10% with 28% specificity and 87.5% sensitivity (Mann et 
al., 2006).  However, in selected, well characterized populations of suicide attempters there 
might be a place for such prediction models (Jokinen et al., 2007). It is important to point out 
that the different biological systems are close related to each other and thus a number of 
different biomarkers would be more suitable to identify a “biosignature for suicide” and 
therefore the individuals who are at risk (Guintivano et al., 2014; Kaminsky et al., 2015; 
Niculescu et al., 2015; Oquendo et al., 2014).  
Furthermore, the use of clinical predictors may help refining the prediction models in suicide. 
Two such important clinical predictors would be the suicide intent of the individual which is 
shown to be an important long term risk factor for suicide in suicide attempters and lifetime 
violent behavior (Freedenthal, 2008; Stefansson et al., 2010; Suominen et al., 2004). 
 
1.2.2 Oxytocin 
 
There is some evidence suggesting that other neuroendocrine systems may be involved in the 
neurobiology of suicidal behavior. Oxytocin is a neuropeptide implicated in social interaction 
and behaviors such as affiliation, trust, aggression and has an important role in early 
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attachment (Heinrichs et al., 2009; Insel, 2010; Neumann, 2009; Olff, 2012). Oxytocin is 
produced in the paraventricular and supraoptic nuclei in the hypothalamus and transferred in 
the posterior hypophysis where it is released. In the central nervous system, oxytocin has its 
effects in the hypothalamus, cortical, brainstem, olfactory areas and amygdala and is 
implicated in depression, anxiety, autism, fear and resilience to stress (Heinrichs et al., 2009; 
Pierrehumbert et al., 2010; Veening et al., 2010). Oxytocin is important in stress regulation 
and interacts with the HPA axis in an inhibitory manner (Neumann et al., 2000; Petersson et 
al., 1999; Windle et al., 2004; Windle et al., 1997). 
 As oxytocin is both involved in the stress response and has major effects on social behavior 
it is reasonable to assume a role in suicidal behavior. Indeed, there is some evidence that 
Oxytocin in involved in suicide. Lee et al. (2009) reported that CSF oxytocin was inversely 
correlated with life history of aggression, a known risk factor for suicide (Lee et al., 2009). 
Interestingly through an exploratory analysis, lower levels of CSF Oxytocin were found in 
suicide attempters compared to patients with no history of suicidal behavior (Lee et al., 
2009).  
 
1.2.3 Dehydroepiandrosterone sulphate (DHEA-S) 
 
DHEA-S is one of the most abundant circulating steroids in humans, and its secretion is 
regulated by adrenocorticotropic hormone, which also regulates the secretion of cortisol.  
Together with DHEA they are synthesized both in the brain and in the adrenals. Unlike 
DHEA, DHEA-S exhibits little circadian rhythmicity due to its very long half-life.  
Both DHEA and DHEA-S have been implicated in different psychiatric conditions such as 
depression, post-traumatic stress syndrome, and schizophrenia.  DHEA-S can modulate 
several neurobiological systems including catecholamines and glutamate, implicated in the 
neurobiology of depression; it has anti-glucocorticoid and neuroprotective effects. DHEA-S 
is important is stress regulation and together with cortisol is taken into account in the 
allostatic load, a measurement of the negative physiological effect of stress over time 
(Maninger et al., 2009). Their ratio (cortisol/DHEA-S) might be a sensitive measure of the 
allostatic load.  Moreover, Morgan et al., (2004 and 2009) in experimental studies of 
submitting individuals under stress reported the positive role of DHEA-S in coping under 
stress conditions (Morgan et al., 2009; Morgan et al., 2004). DHEA-S is also considered a 
marker for psychophysiological well-being (Maninger et al., 2009). 
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Even though DHEA-S is investigated in depression and elevated cortisol/DHEAS ratios has 
been proposed to be a state marker of depressive illness, (Maninger et al., 2009) there are 
very few studies of the relationship of DHEA-S and suicidal behavior. A study of Butterfield 
et al., (2005) reported that male veterans with PTSD and suicide attempt had higher plasma 
DHEA levels compared to patients with no suicide attempt (Butterfield et al., 2005). 
It is important to mention that most of the studies of biological systems in suicide may have 
been confounded by other factors such as current psychopathology with depressive 
symptoms, symptoms of post traumatic syndrome, anxiety as well as exposure to childhood 
adversity. All the above mentioned possible confounders have been reported to affect the 
HPA axis independently of suicide behavior and especially the effects of childhood trauma 
are independent of psychopathology in general. Early live adversity has longstanding effects 
in adulthood through alternations of biological systems (Heim et al., 2008b).  
 
1.3 HYPERSEXUAL DISORDER 
 
Sexuality is a central part of human behavior and the most essential in an evolutionary aspect. 
Psychiatric disorders may have effects on sexuality and sexual symptoms are included in their 
diagnostic criteria such as depression, bipolar disorder and personality disorders (DSM 5). 
Some aspects of risky sexual behavior such as the infrequent use of condom and the early 
onset of sexual behavior are even related with increased suicidality (Mota et al., 2010).  
Hypersexual disorder has been described previously in the literature with different names 
reflecting different models such as sexual addiction, compulsive sexual behavior, sexual 
impulsive behavior and sexual lust dysregulation (Bancroft et al., 2009; Garcia and Thibaut, 
2010; Kafka, 2010). 
Hypersexual Disorder (HD) is conceptualized as a nonparaphilic sexual desire disorder with 
an impulsivity component integrating various pathophysiological perspectives such as sexual 
desire deregulation, sexual addiction, impulsivity and compulsivity and was proposed as a 
diagnosis to be included in the DSM 5 (Kafka, 2010). Furthermore, hypersexual behavior is 
proposed to be a maladaptive response to dysphoric affective states as well as life stressors 
(Kafka, 2010). 
Hypersexual disorder includes repetitive and intense preoccupation of the patient with sexual 
behavior, urges and fantasies that are difficult to control resulting in negative consequences 
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and significant impairment and/or distress for the individual in different areas such as social 
contacts and work (Kafka, 2010). The negative consequences might be isolation, depressive 
and anxiety symptoms, unwanted pregnancies and sexual transmitted diseases. Långström 
and Hanson (2006) reported also that individuals with hypersexuality had more negative 
health indicators as well as life problems (Langstrom and Hanson, 2006). Examples of 
hypersexual behavior include masturbation, use of pornography, sex with consenting adults 
and sexual activities related to the use of internet (Kafka, 2010).  
There is still no full consensus on the conceptualization of the hypersexual disorder and there 
was a debate when proposed for inclusion as a diagnosis in the DSM-5 (Kafka and Krueger, 
2011; Moser, 2011). Finally, it was not included in the DSM-5, although the proposed criteria 
showed high validity and reliability at the field study (Reid et al., 2012). Kafka has also 
addressed the criticism against the exclusion of hypersexual disorder (Kafka, 2014; Kafka 
and Krueger, 2011). 
Although there have been problems with methodology as there was no consensus regarding 
hypersexual disorder, the literature indicates that hypersexual behavior affects 3-6% of the 
population (Kafka, 2010; Langstrom and Hanson, 2006).  Långström and Hanson, (2006), in 
a population based study  reported that 12% of men and 7% of women could be classified as 
hypersexual although that did not necessarily classified them as having hypersexual disorder.   
There are high rates of comorbidity between hypersexual disorder and other psychiatric 
conditions. The most common are depression and anxiety such as social phobia but also 
substance abuse and ADHD (Kafka, 2010). Schultz et al., (2014) reviewing the literature 
reported positive moderate correlation between symptoms of depression and hypersexual 
behavior (Schultz et al., 2014).  
 
1.3.1 Biological systems in hypersexual disorder 
 
Even though human sexuality is very strongly related to cultural factors, biological systems 
offer the matrix to understand sexual behavior. Central mechanisms including the limbic 
system, neuroendocrine control as well as the inhibition from the frontal lobe regulate the 
human sexual behavior (Goldey and van Anders, 2012; Ragan and Martin, 2000). The sexual 
response is controlled by monoamines noradrenaline, dopamine, serotonin as well as 
acetylcholine, neuropeptides, glutamate and GABA (Bancroft, 2002; Saleh and Berlin, 2003).  
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Bancroft (2002) suggests a model with both excitatory and inhibitory factors in the brain, 
where the sexual response is based on the balance between them. 
Although HPA axis dysregulation has been reported in a number of psychiatric populations 
most commonly with the use of the dexamethasone suppression test (DST) (Sher, 2006), the 
relationship between stress and sexual behavior is not clear. Some studies on the HPA axis 
proposed a negative effect on sexual behavior while others indicate a facilitative effect 
(Goldey and van Anders, 2012).  The existing research has focused on alternations of the 
stress system as a direct effect of sexual behavior. Exton et al. reported unchanged plasma 
cortisol levels in individuals watching a film that would induce sexual arousal and during 
sexual arousal and orgasm (Exton et al., 2001; Exton et al., 2000). Additionally, sexual 
arousal but not sexual thoughts during an imagined social situation exercise were positively 
related to salivary cortisol at baseline (Goldey and van Anders, 2012).   
The HPA axis besides being a central part of the stress system, also interacts directly with the 
Hypothalamus Pituitary Gonadal (HPG) axis and thus controls the secretion of steroid 
hormones such as testosterone and estradiol (Cunningham et al., 2012). Both testosterone and 
estradiol have a very important role in sexual drive and behavior but their exact role is far 
from clarified (Cunningham et al., 2012; Saleh and Berlin, 2003). Other androgens that have 
the ability to transform to testosterone and estradiol as well as DHEA-S that is related to 
feelings of wellbeing may be relevant to male sexuality.  
Other hormones may be also related to sexual behavior. Prolactin is proposed to have an 
inhibitory effect on sexual behavior through the inhibition of dopaminergic activity 
(Bancroft, 2005) and oxytocin with its key role in affiliative behavior, childbirth and 
reproduction may be implicated in sexual behavior by both central and peripheral 
mechanisms. 
Regarding hypersexual disorder, very little is known about the neurobiology behind this 
disorder and especially about the role of neuroendocrine systems. In a sample of healthy 
young adults, Harrison et al. reported increased salivary cortisol reactivity as a response to a 
psychological stressor (imagined social situation exercise) in individuals with risky sexual 
behavior (Harrison et al., 2014). These mixed results on the role of HPA axis and other 
neuroendocrine systems in human sexuality remain to be clarified and particularly in deviant 
expressions of human sexuality such as in hypersexual disorder. It is also important to notice 
that possible confounders, when evaluating neuroendocrine systems, such as the exposure to 
childhood adversity should be taken under consideration. 
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1.4 EARLY ADVERSITY AND PSYCHOPATHOLOGY 
 
It is important to mention that the exposure to childhood adversity, emotional and physical 
abuse and neglect has been shown to increase both the risk for psychopathology in adulthood 
and suicide (Brodsky and Stanley, 2008; Jokinen et al., 2010; Teicher and Samson, 2013; van 
Heeringen and Mann, 2014). Childhood adversity is also related to adversity in adult life, 
increasing the risk for revictimization (Widom et al., 2008). 
The relationship between childhood trauma and hypersexual behavior is very important with 
Långström and Hanson reporting that individuals with hypersexuality were more often 
coming from adverse family backgrounds (Langstrom and Hanson, 2006). In addition, 
childhood adversity is suggested as a mediator of increased risk for the development of risky 
sexual behavior and especially sexual abuse is suggested to be directly linked to 
hypersexuality (Aaron, 2012; Wilson and Widom, 2008). The younger the age of the victim 
when sexually abused and male gender were suggested to lead to hypersexual behavior 
(Aaron, 2012).  
The mechanism through childhood adversity increases risk for psychopathology in adult life 
is suggested to be via the long standing effects and alternation of the neurobiological systems 
that occurs due to the exposure to childhood adversity (De Bellis and Zisk, 2014; Lupien et 
al., 2009; Turecki, 2014; Turecki et al., 2012; van Heeringen and Mann, 2014).  These 
alternations have functional consequences in adult life as the homeostasis of the 
neurobiological systems is dysregulated. De bellis and Zisk present twelve different 
mechanisms in how childhood adversity affects the HPA axis but also other neurobiological 
systems that are involved such as the serotonin and the oxytocin system. Individual 
differences, the gender, the timing of the trauma, duration and severity as well as genetic, 
epigenetic and social factors are important in the development of the effects of the trauma on 
the biological systems and psychopathology (De Bellis and Zisk, 2014).  
The most common finding when investigating adults with childhood adversity is low levels 
of cortisol (De Bellis and Zisk, 2014; Heim et al., 2001). Contrary, Heim et al., showed 
increased cortisol and ACTH responses at the dexamethasone/CRF test in depressed men 
with a history of childhood abuse compared to healthy controls and depressed men without a 
history of childhood abuse (Heim et al., 2008a). This is not necessarily contradicting as 
different mechanisms may be in place (De Bellis and Zisk, 2014). 
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Regarding suicide there is increasing evidence of the biological effects of childhood adversity 
leading to vulnerability to suicide (Heim et al., 2008b; Turecki, 2014; Turecki et al., 2012). 
The main effect is proposed to be through a dysregulation of the HPA axis and the regulation 
of neurotrophic factors such as the brain derived neurotrophic factor (BDNF) through genetic 
and epigenetic mechanisms (Turecki et al., 2014).   
But also steroids such as DHEA-S that are in close relation with glucocorticoids are related to 
childhood adversity.  Kellner et al., when investigating patients with post-traumatic stress 
disorder and exposure to childhood abuse found increased plasma levels of DHEA and 
DHEA-S in the group exposed to childhood abuse (Kellner et al., 2010). On the other hand, 
Pico Alfonso et al., measuring salivary DHEA did not found a significant difference in 
DHEA levels in women exposure to childhood abuse (Pico-Alfonso et al., 2004). A 
decreased plasma cortisol/DHEA(S) ratio has also been reported in patients with post-
traumatic stress disorder and exposure to childhood abuse (Kellner et al., 2010; Yehuda et al., 
2006) and Yehuda et al., proposed that DHEA-S promotes resilience and thus has a protective 
role in childhood trauma (Yehuda and Flory, 2007). DHEA-S has been mainly measured in 
saliva or in plasma during most studies and only a few studies in psychiatric patients have 
measurements in the cerebrospinal fluid (Kancheva et al., 2011). 
The oxytocin system is also closely related to early adversity related psychopathology (De 
Bellis and Zisk, 2014). Heim et al., found lower CSF Oxytocin concentrations in women with 
a history of childhood abuse compared with women without childhood abuse (Heim et al., 
2009). Similarly, in healthy men plasma oxytocin levels were negatively associated with 
early life adverse experiences (Opacka-Juffry and Mohiyeddini, 2012) and likewise Bertsch 
et al., found a negative correlation between plasma oxytocin levels  and childhood trauma 
when investigating women with borderline personality disorder (Bertsch et al., 2013). On the 
other hand, Pierrehumbert et al., reported that abused women had higher baseline oxytocin 
levels and premature suppression of oxytocin in a study using the Trier Social Stress Test, an 
experimental psychosocial challenge (Pierrehumbert et al., 2010). In the same line, Seltzer et 
al., reported high levels of oxytocin secretion only in girls with a history of childhood abuse 
that underwent the Trier Social Stress Test for children while there was no difference in boys 
(Seltzer et al., 2014). Furthermore, Thompson et al., showed an interaction between high 
early adversity and the oxytocin transporter rs2254298 polymorphism in predicting anxiety 
and depressive symptoms in a in a group of adolescent girls (Thompson et al., 2011).
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2 AIMS 
2.1 OVERALL AIMS 
The aim of this thesis was to investigate different neuroendocrine systems with focus on the 
HPA axis, Oxytocin and DHEAS in suicide attempters and in patients with Hypersexual 
Disorder. These neuroendocrine systems were investigated in relation to exposure to 
childhood adversity and interpersonal violence as well as different aspects of 
psychopathology such as suicide intent, depressive symptoms and hypersexual behavior.  
The specific research aims were as follows: 
2.2 STUDY I 
To investigate CSF and plasma Oxytocin levels in suicide attempters and healthy volunteers. 
Another aim was to assess the relationship between CSF and plasma Oxytocin levels, suicide 
intent and lifetime expressed interpersonal violence in suicide attempters. The final aim was 
to assess whether CSF and plasma oxytocin would predict subsequent suicide in suicide 
attempters. 
2.3 STUDY II 
To investigate CSF levels of 5-Hydroxyindoleacetic acid (5-HIAA) and CSF and plasma 
levels of cortisol and DHEAS in suicide attempters and healthy volunteers. Another aim was 
to investigate the relationship between neuroendocrine measurements and childhood 
adversity in suicide attempters. The final aim was to investigate whether CSF cortisol, 5-
HIAA or DHEAS levels would predict subsequent suicide. 
2.4 STUDY III 
To assess the association between CSF and plasma Oxytocin levels and lifetime trauma 
history (exposure to interpersonal violence as a child, as an adult or during both periods) in 
suicide attempters. Another aim was to assess the relationship between CSF and plasma 
oxytocin and childhood emotional climate.  
2.5 STUDY IV 
To investigate the function of the HPA axis in hypersexual disorder and assess the 
relationship of neuroendocrine measurements to childhood adversity and hypersexual 
behavior.
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3 METHODS 
 
3.1 STUDY SETTINGS 
 
Studies I, II and III: Patients who were admitted after a suicide attempt at the psychiatric 
wards at the Karolinska University Hospital and accepted to participate in a study of 
biological and psychological risk factors for suicidal behavior. Healthy volunteers were also 
recruited as a control group.  
Study IV: Patients with hypersexual behavior seeking medical and/or psychotherapeutic 
treatment at the Center for Andrology and Sexual Medicine (CASM), at the Karolinska 
University Hospital were invited to participate in a study of biological markers for 
hypersexual behavior. Healthy volunteers were also recruited as a control group. 
 
3.2 PARTICIPANTS IN THE SUICIDE ATTEMPTERS COHORT (STUDIES I-III) 
 
Suicide attempters 
 
Studies I-III are based on a cohort of suicide attempters that were included between the years 
1988 and 1991. The sample of twenty eight (28) suicide attempters includes eighteen (18) 
men, and ten (10) women. The mean age of the men was 44 years, range 23-65 years,  
standard deviation (SD) = 14.6 while the women had a mean age of 41 years, range 26-66 
years, standard deviation (SD) =12.3. All suicide attempters were medication free. 
The inclusion criteria of this cohort were a recent suicide attempt and the age of 18 years or 
older. The suicide attempt was defined as any nonfatal, self-injurious behavior with at least 
some intent to die. The exclusion criteria included schizophrenia spectrum psychosis, 
intravenous drug abuse, or circumstances where informed consent could not be obtained. 
All the suicide attempters were interviewed by trained psychiatrists using the SCID I research 
version interview to establish psychiatric diagnoses according to DSM-III (American 
Psychiatric Association 3
rd
 edition).The SCID II interview was used to assess Axis II 
diagnoses.  
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The criteria by Träskman et al. were used to assess whether the suicide attempt was 
considered violent. According to these criteria the use of all violent methods (e.g., firearm, 
hanging, jumping from a high place, car exhaust) classify as a violent suicide attempt 
whereas suicide attempts involving drug overdose or superficial phlebotomy are classified as 
non-violent. According to these criteria, five patients (18%) had used a violent suicide 
attempt method (Traskman et al., 1981). 
Ninety-three per cent of the patients (n=26) had at least one current Axis I or Axis II 
psychiatric diagnosis. Eight (n=8) patients had more than one Axis I diagnosis. Among Axis 
II diagnoses, two thirds of the patients fulfilled criteria for a personality disorder and one 
patient was diagnosed with an organic personality syndrome. Table 1 shows Axis I and Axis 
II diagnoses.  
Table 1. Psychiatric diagnoses in suicide attempters 
 
DSM III Axis 1 
diagnosis 
Number of suicide 
attempters 
DSM III Axis 2 
diagnosis 
Number of suicide 
attempters 
Mood disorders 13 Paranoid  2 
Bipolar disorder 1 Schizoid  1 
Alcohol abuse 6 Dependent 1 
Alcohol addiction 3 Passive-aggressive 1 
Adjustment disorder 3 Borderline  6 
Anxiety disorder 6 Antisocial 2 
Organic personality 
syndrome 
1 Avoidant  2 
Anorexia nervosa 1 Mixed  1 
No axis 1 diagnosis 4 No axis 2 diagnosis 8 
Not assessed 0 Not assessed 4 
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Healthy Volunteers 
 
Nineteen (19) healthy volunteers including twelve (12) men and seven (7) women were 
recruited as a control group. The healthy volunteers were screened with the SCID interview 
by a trained psychiatrist in order to exclude previous or current psychiatric or medical 
conditions. The healthy volunteers had a mean age of 30 years (range: 23-48).  
 
3.3 PARTICIPANTS IN THE HYPERSEXUAL DISORDER COHORT (STUDY IV) 
 
Patients with hypersexual disorder 
 
Sixty seven (n= 67) male patients with hypersexual disorder, (mean age 39.2 years, range19-
65) were included between the years 2013 and 2014 at the Center for Andrology and Sexual 
Medicine, (CASM), which is a multidisciplinary center for diagnostics and treatment of 
patients with sexual dysfunctions. The recruitment of the patients was through advertising in 
media as well as referrals to the Center for Andrology and Sexual Medicine. 
The inclusion criteria were a diagnosis of hypersexual disorder, available contact information 
and the age of 18 years or older. The exclusion criteria were current psychotic illness, current 
alcohol or drug abuse, other psychiatric disorder that would require immediate treatment such 
as major depression with high suicidal risk and serious physical illness such as severe hepatic 
or renal disease.  
The patients were after initial contact with the study coordinators asked to log into a web 
based platform, leave their preliminary informed consent to participate in the study, and 
complete their personal information as well as the self-rated questionnaires. Subsequently, all 
patients were evaluated in a face to face interview by a trained psychiatrist and a psychologist 
using the Mini International Neuropsychiatric Interview (MINI) (Sheehan et al., 1998)  to 
establish psychiatric diagnoses and the diagnosis of hypersexual disorder. Eligible patients 
gave their final written informed consent and were included in the study. Seven (n=7) patients 
had more than one diagnosis and five (n=5) had more than one anxiety diagnosis. Table 2 
shows the diagnoses and characteristics of the patients with hypersexual disorder. 
 16 
Table 2. Diagnoses and characteristics of the patients with hypersexual disorder. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Healthy volunteers 
 
Forty male healthy volunteers (n=40) were recruited from the Karolinska Trial Alliance 
(KTA) database. KTA was founded by a collaboration of Stockholm County Council and the 
Karolinska Institutet and functions as a Clinical Research Center at Karolinska University 
Hospital. The first phase included a telephone pre-screening when the volunteers gave their 
informed consent. To be included, healthy volunteers should have been physically healthy 
with no serious illnesses, no previous or ongoing psychiatric illness and no first degree 
relatives with schizophrenia, bipolar disorder or completed suicide. Finally they should not 
have been exposed to serious trauma such as assault and natural disasters that required 
treatment or caused disability. 
Diagnosis and characteristics Number of patients 
Depression n=11, 16.4% 
Anxiety 
Social Phobia 
Panic syndrome 
Obsessive compulsive disorder 
Generalized Anxiety Disorder 
Post-Traumatic Stress Syndrome 
n=12, 17.9% 
n=8 
n=4 
n=2 
n=2 
n=1 
Diagnosis (other) n= 1, (ADHD) 
History of Suicide attempt n=8, 11.9% 
Antidepressants n=11, 16.4% 
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The healthy volunteers followed the same procedure as the patients with HD, after initial 
contact with the study coordinators they were asked to log into the Web based platform, leave 
their preliminary informed consent to participate in the study, and complete their personal 
information as well as the self-rated questionnaires. Individuals who screened positive for 
pedophilic disorder were excluded from the study. Written informed consent was given 
before the baseline blood samples were taken. One individual was excluded, due to medical 
illness that was withheld in the pre-screening but was evident from the laboratory results. The 
total number of healthy volunteers was thirty nine (n = 39). An effort was made to match the 
group of healthy volunteers to our patients with HD regarding age. Possible seasonal 
variations were minimized by matching time of blood sampling to either spring or fall. The 
mean age of the healthy volunteers was 37.5 years (range 21-62). 
 
3.4 ASSESSMENT OF CHILDHOOD ADVERSITY, EXPOSURE AND 
EXPRESSED INTERPERSONAL VIOLENCE IN CHILDHOOD AND ADULT 
LIFE IN SUICIDE ATTEMPTERS 
 
Study I-III:  
Karolinska Interpersonal Violence Scale (KIVS) contains four subscales assessing 
expressed violent behavior as well as exposure to violence in childhood (between 6 and 14 
years of age) and during adult life (15 years or older) (Jokinen et al., 2010). The ratings are 
based on a semi structured interview and the items were scored 0-5. Interviews and ratings 
were performed by trained clinicians. Revictimization was defined as having both ratings 
above the mean and the sum score 6 or above. 
Study III: 
Childhood emotional climate factor of the Socialization subscale from the Karolinska 
Scales of Personality (KSP) was used to assess childhood emotional climate. The 
Socialization subscale consists of 20 items, with emphasis on negative childhood 
experiences, poor school and family adjustment, and general dissatisfaction. Eight of the 
items reflect negative childhood emotional climate, 4 items reflect childhood adjustment 
problems and 8 items assess feelings of resentment and victimization (Svanborg et al., 1999).  
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3.5 ASSESSMENT OF DEPRESSION SEVERITY IN SUICIDE ATTEMPTERS 
(STUDIESI-III) 
 
Montgomery-Åsberg Depression Rating Scale (MADRS): It was used to assess the 
severity of depression. It consists of 10 items based on a clinical interview evaluating 
apparent sadness, reported sadness, inner tension, sleep, appetite, concentration, lassitude, 
inability to feel, pessimistic and suicidal thoughts. Total scores range 0-60 points 
(Montgomery and Asberg, 1979). 
 
3.6 ASSESSMENT OF SUICIDE INTENT OF THE SUICIDE ATTEMPTERS 
(STUDY I) 
 
Suicide intent was measured with two different instruments. Beck’s Suicide Intent Scale 
(SIS), was the first instrument with 15-items and is designed to examine the factual aspects of 
the suicide attempt. These are the patient’s thoughts and feelings as well as the circumstances 
at the time of the suicide attempt (Beck, 1974). Individual responses are coded on a 0-2 scale 
and the total SIS range is between 0-30 reflecting low to high suicide intent. A factor analysis 
of SIS (Mieczkowski et al., 1993) defined the components of suicide intent and the planning 
subscale (items 1–7, 15) was used separately in the analysis. 
The second instrument was the Freeman scale (Freeman, 1974) that takes into account the 
type and quantity of drugs used or the extent of self-injury inflicted. A high score on the scale 
indicates ‘low reversibility of suicidal method’ (i.e. serious attempt) and a low score indicates  
‘high reversibility’ (i.e. non-serious attempt). The Freeman scale includes a second part rating 
the likelihood that someone would interrupt the attempt (Freeman interruption probability). 
Individual responses are coded on a 1-5 scale and the total Freeman range is between 2 and 
10. 
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3.7 MEASUREMENTS OF BIOMARKERS IN THE SUICIDE COHORT (STUDIES 
I-III) 
 
Shortly after the suicide attempt  at approximately 8 am, after fasting in bed since midnight, 
blood samples (10 ml) were collected in tubes containing heparin (10 IU ml l) and were 
centrifuged. The plasma was removed and frozen at -80 °C.  
Fifteen minutes after the blood samples were collected lumbar punctures were performed in a 
standardized manner between 8 and 9 am. Twelve (12) ml CSF was withdrawn with the 
participant in the sitting position and the needle being inserted between lumbar vertebrae IV 
and V. CSF was immediately centrifuged and aliquoted in six 2 ml samples and stored at -80 
°C. All biochemical analyses were contemporaneous with the clinical protocol. 
 
3.7.1 CORTISOL and DHEAS 
 
The concentrations of cortisol and DHEAS in plasma and CSF were measured according to 
radioimmunoassay (RIA) methods (Hedman et al., 1989). The antisera for DHEA were 
prepared in our laboratory. The methods were validated for the assay of sulphoconjugated 
steroids as earlier described (Hedman et al., 1989). The intra- and inter assay coefficients of 
variation never exceeded 10% and 20% respectively. 
 
3.7.2 5-HIAA 
 
CSF 5-HIAA was analyzed by using mass fragmentography (GC–MS) according to methods 
developed by Bertilsson. The coefficient of variation of the analytical method is less than 5% 
(Bertilsson, 1981). 
 
 20 
3.7.3 OXYTOCIN 
The concentration of oxytocin in plasma and CSF was measured with specific radio-
immunoassay (RIA) using the antibody KA19 (Milab, Malmo, Sweden). The limit of 
oxytocin detection was 2 fmol/mL and the intra- and inter-assay coefficients of variation were 
11.2 and 13%, respectively (Stock and Uvnas-Moberg, 1985; Uvnas-Moberg et al., 1993). 
 
3.8 MORTALITY IN THE SUICIDE ATTEMPTERS COHORT (STUDY I-II) 
 
All the patients were linked to the Cause of Death register, maintained by the National Board 
of Health and Welfare in Sweden (http://www.socialstyrelsen.se) by using the unique 
personal identification number. The cause of Death register is based on information from the 
death certificates. Six patients (two women and four men) had committed suicide before 
April 2011; suicides were ascertained from the death certificates. The follow up time ranged 
between 20 and 22 years. 
 
3.9 ASSESSMENTS IN THE HYPERSEXUAL DISORDER COHORT (STUDY IV) 
 
3.9.1 PSYCHIATRIC DIAGNOSES 
 
The diagnostic process was based on a clinical interview by a trained psychiatrist and 
psychologist. The Mini-International Neuropsychiatric Interview (MINI 6.0), a validated, 
structured diagnostic clinical interview for assessing psychopathology along the Axis I 
(Sheehan et al., 1998), was used during the interview. 
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3.9.2 DIAGNOSIS OF HYPERSEXUAL DISORDER 
 
The diagnosis of hypersexual disorder was defined according to the criteria proposed during 
the revision of DSM 5 by Kafka (2010). These criteria include: 
A. Over a period of time of at least six months, recurrent and intense sexual fantasies, sexual 
urges, or sexual behaviors in association 4 or more of the following 5 A criteria: 
A1. Time consumed by sexual fantasies, urges or behaviors repetitively interferes with other 
important (non-sexual) goals, activities and obligations. 
A2. Repetitively engaging in sexual fantasies, urges or behaviors in response to dysphoric 
mood states (e.g., anxiety, depression, boredom, irritability). 
A3. Repetitively engaging in sexual fantasies, urges or behaviors in response to stressful life 
events. 
A4. Repetitive but unsuccessful efforts to control or significantly reduce these sexual 
fantasies, urges or behaviors. 
A5. Repetitively engaging in sexual behaviors while disregarding the risk for physical or 
emotional harm to self or others. 
B. There is clinically significant personal distress or impairment in social, occupational or 
other important areas of functioning associated with the frequency and intensity of these 
sexual fantasies, urges or behaviors. 
C. These sexual fantasies, urges or behaviors are not due to the direct physiological effect 
exogenous substance (e.g., a drug of abuse or medication). 
Specify if: masturbation, pornography, sexual behavior with consenting adults, cybersex, 
telephone sex, strip clubs, other. 
 
3.9.3 ASSESSMENTS OF HYPERSEXUAL BEHAVIOR, DEPRESSION 
SEVERITY AND CHILDHOOD ADVERSITY 
 
The following self-rated scales were administrated by the Wed based platform: 
 22 
Hypersexual disorder screening inventory (HDSI):  
It is consisted of 7 items that follow the criteria (5A and 2B criteria) of hypersexual disorder. 
These are graded 0-4, from “never true” to “almost always true” during the past 6 months. 
The total score ranges from 0 to 28. In order to be diagnosed with Hypersexual Disorder a 
minimum score of 3 is required on 4 out of 5 A-criteria, and 3 or 4 points on a minimum of 1 
B-criteria is required with minimum total score of 15 (www.dsm5.org). 
 
Sexual Compulsivity Scale (SCS):  
It consists of 10 statements about sexually compulsive behavior, sexual preoccupations, and 
sexually intrusive thoughts that respondents are called to endorse agreement with. Agreement 
is on 4-point scale (1 “not at all like me” to 4 “very much like me”) with total score range 10-
40.  <18 is classified as not sexually compulsive, 18-23 as mild sexual compulsivity, 24–29 
as moderate and >30 as sexually compulsive. SCS was first developed for the assessment of 
high-risk sexual behaviors (Kalichman and Rompa, 1995). 
 
Hypersexual Disorder: Current Assessment Scale (HD:CAS):  
It contains seven questions with the first one (A1) asking for the type as well as the number 
of sexual behaviors reported (including masturbation, pornography, sex with consenting 
adults, cybersex, telephone sex, strip clubs, and other sexual behaviors). The remaining six 
questions (A2-A7) quantify these symptoms during the most recent 2-week time frame thus 
assessing the current state of hypersexual behavior. Each question (A2-A7) is rated in a 5 
point intensity scale (0-4) with total scores from 0 to 24 points. HD:CAS is considered to be 
the dimensional measurement of hypersexual behavior. 
 
Montgomery-Åsberg Depression Rating Scale Self rating (MADRS-S):  
It was used to assess the severity of depression (Svanborg and Asberg, 2001). The rating 
scale includes nine questions on depressive symptoms, rated from 0 to 6 points, with total 
scored 0–54. 
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Childhood Trauma Questionnaire (CTQ): 
CTQ is a psychometric instrument for the assessment of childhood trauma. It is consisted by 
five subscales, measuring Emotional Abuse (EA), Physical Abuse (PA), Sexual Abuse (SA), 
Emotional Neglect (EN) and Physical Neglect (PN).  Each subscale consists of 5 items and 
gets scores between 5 and 25 and classifies maltreatment as none, low, moderate and severe. 
The CTQ is completed with 3 items that constitute the minimization/denial scale used to 
identify individuals who may be underreporting traumatic events. Thus the total CTQ 
includes 28 items (Bernstein and Fink, 1998). 
 
3.10 MEASUREMENTS OF CORTISOL AND ACTH IN THE HYPERSEXUAL 
DISORDER COHORT 
 
Blood sampling for patients and healthy volunteers were performed all year round in order to 
have subject and volunteer samples equally distributed between spring and fall. All blood 
samples were taken at approximately 8 am. The analyses were performed directly after 
sampling at the laboratory of the Karolinska University Hospital using a chemiluminescence 
immunoassay with sensitivity for ACTH of 0.5 pmol/l, (normal range 1.6–13.9 pmol/l) and 
sensitivity for Cortisol 15 nmol/l (normal range 200–800nmol/l). Inter assay and intra assay 
coefficients of variation were1.3% and 1.5% for Cortisol and 0.6% and 3.5% for ACTH. 
 
3.11 DEXAMETHASONE SUPPRESSION TEST IN HYPERSEXUAL DISORDER 
 
After the baseline plasma samples of ACTH and Cortisol were gathered, all patients with HD 
and healthy volunteers underwent a low dose dexamethasone suppression test. 0.5 mg of 
dexamethasone was administrated orally at 23:00 h the same day as the baseline sample was 
taken. Post dexamethasone suppression test blood samples were collected the next day at 
approximately at 08:00 h, using the same method as for baseline Cortisol. A plasma Cortisol 
level of 138 nmol/l (=5 g/dl) or higher in the morning sample after dexamethasone 
administration classified as non-suppressed. 
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3.12 STATISTICAL ANALYSES 
 
Initial analyses were carried out to evaluate skewness and kurtosis of the distributions in with 
Shapiro-Wilks test (studies I, III and IV) or with Kolmogorov test (study II). In study I data 
for CSF and plasma oxytocin were transformed into normal distribution using the natural 
logarithms before statistical analysis. 
As the healthy volunteers were younger than patients, the group comparison of oxytocin 
levels (study I) was adjusted for age using linear regression. In study II as DHEA-S levels 
decline strongly with age, while cortisol levels increase modestly (o Hartaigh et al., 2012), all 
group comparisons of hormone values were adjusted for age using linear regression. Group 
differences were assessed with Anova (study II), Wilcoxon test (study II and III), the 
Kruskal-Wallis’ test (study IV) and t-test (study III, IV) in continuous variables. Fisher’s 
exact test was used for cross tabulations of categorical variables (study II) and to detect group 
differences between patients and healthy volunteers, in the rates of cortisol non-suppression 
after dexamethasone challenge (study IV).  
In study II as comorbid substance abuse diagnosis and depression severity showed a trend for 
significant correlation with CSF and plasma cortisol levels and CSF 5-HIAA levels, group 
comparisons between patients and healthy volunteers were also adjusted for diagnosis of 
major depression and comorbid diagnosis of substance abuse. CSF or plasma DHEAS did not 
differ significantly between patients with and without diagnosis of major depression or 
substance abuse (p values between 0.49 and 0.92), and therefore the group comparisons were 
adjusted only for age. Men and women were assessed separately adjusting the group 
differences between male suicide attempters and male healthy volunteers as well as female 
suicide attempters and female healthy volunteers as above. 
Correlation analyses were used to determine associations between the clinical ratings and 
biologic variables. Tests of non-parametric or parametric correlations were performed using 
Spearman rho (study I,II, III,IV) or Pearson’s r(I,II,IV). Post-hoc power analysis indicated 
that only large effect sizes could be detected. The effect sizes were calculated using Cohen’s 
d (Cohen, 1992).  
From the results of the correlational analyses, standard regression analyses were conducted. 
In study I, standard regression analysis was conducted to determine whether CSF oxytocin 
could be predicted by suicide intent and lifetime violent behavior corrected for age and 
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gender. In study II, standard regression analysis was conducted to determine whether CSF 
cortisol/DHEAS ratio could be predicted by exposure to violence as a child corrected for age, 
gender and depression severity. Median split subgrouping for further analysis of CSF 5-
HIAA and CSF cortisol levels in suicide victims and survivors was applied. In study IV, 
standard regression analysis was conducted to determine whether DST non-suppression and 
plasma ACTH could be predicted by the diagnosis of hypersexual disorder adjusted for 
childhood trauma. All statistical tests were two-tailed. An ad hoc receiver-operating 
characteristic (ROC) analysis was used to find optimal threshold for DST cortisol level to 
predict hypersexual disorder diagnosis. ROC table and curve were created to establish the 
optimal cut-off value and ROC area under the curve (AUC) was determined as a measure of 
the diagnostic execution according to the methods of Hanley and McNeil. 
The p value was set at <0.05. The Statistical Package JMP VI software, SAS Institute Inc., 
Cary, NC, USA was used for all statistical analyses. 
 
3.13 ETHICAL CONSIDERATIONS 
 
Studies I-III: The Regional Ethical Review Board in Stockholm approved the study 
protocols (Dnrs: 88—216; 91—96; 2010/3:4) and the participants gave their written informed 
consent to the study. The suicide attempters are in a high risk for subsequent suicide and 
especially in this cohort with high levels of psychopathology. Thus research of such 
vulnerable groups is of high importance as it may lead to gain knowledge that hopefully leads 
to a better understanding of the mechanisms behind suicide which is one of the leading causes 
of mortality in the world.  
Studies IV: The study protocols were approved by the Regional Ethical Review Board in 
Stockholm (Dnrs:2013/1335-31/2) and the participants gave their written informed consent to 
the study. Hypersexual disorder is accompanied with suffering, adverse consequences and 
possible neurobiological alterations in patients with hypersexual disorder were at the time of 
project planning unknown. The knowledge that derives from this research has the potential to 
contribute significantly to the understanding of this disorder.  
The relationship of the potential biomarkers to childhood adversity may give insight to 
biological mechanisms that contribute to psychopathology as the outcome. Consequently, the 
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study of this relationship becomes of high importance as childhood adversity is a great target 
for prevention both at the individual level and from policy makers.  
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4 RESULTS 
4.1 CLINICAL RATINGS IN SUICIDE ATTEMPTERS AND IN HYPERSEXUAL 
DISORDER 
4.1.1 Depression severity, Suicide intent, Interpersonal Violence and 
Revictimization in suicide attempters  
Clinical ratings of suicide attempters are presented in Table 3.  
Table 3. Clinical ratings of depression severity, suicide intent, expressed and exposed 
interpersonal violence and revictimization in suicide attempters 
Ratings Mean Median S.D. Range 
MADRS (N=27) 20.7 19 10.3 4-38 
KIVS, Expressed violent behaviour lifetime (N=24) 2.9 2.5 2 0-7 
KIVS, Exposure to violence as a child  (N=24) 2.5 2.5 1.6 0-5 
KIVS, Exposure to violence as an adult (N=24) 1.9 2 1.6 0.5 
KIVS, Revictimized, Exposure to violence (N=8) 7.8 8 1.4 6-9 
KIVS, Non-Revictimized, Exposure lifetime (N=15) 2.7 3 1.5 0-5 
Childhood emotional climate (revictimized) (N=8) 16.1 16 3.7 10-21 
Childhood emotional climate (non-revictimized) (N=15) 22.5 24 5.7 11.29 
SIS (N=23) 17.9 18 5 8-27 
Planning SIS (N=23) 8.4 9 3.6 3-16 
Freeman reversibility of the suicide attempt method (N=25) 2.8 3 1 1-5 
Freeman probability of intervention (isolation) (N=25) 3.2 3 1.1 1-5 
Freeman total (N=25) 6 6 1.6 2-9 
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There was a significant correlation between the exposure to interpersonal violence as a child 
and exposure as an adult (rho= 0.58, p=0.004). Childhood emotional climate showed a 
significant negative correlation with KIVS exposure to interpersonal violence as a child and 
exposure as an adult ratings (rho=-0.63, p=0.005; rho=-0.64, p=0.004). The correlation 
between KIVS exposure to violence as a child and depression severity measured with 
MADRS was non-significant (r=0.09, n=22, p=0.7). 
Revictimization 
Eight suicide attempters (5 women and 3 men, mean age = 42 years) were characterized as 
revictimized and 15 as non-revictimized (3 women and 12 men, mean age = 43 years). Total 
lifetime trauma exposure in revictimized suicide attempters was significantly higher 
compared to non-revictimized suicide attempters (F-ratio=63.1, p<0.0001). Figure 2. 
Childhood emotional climate scores were significantly lower in revictimized suicide 
attempters compared to non-revictimized suicide attempters (p=0.02). 
There was no difference in depression severity (MADRS) or in comorbidity with personality 
disorder or substance abuse between revictimized and with non-revitimized patients (p-values 
0.47–0.84). 
 
                                           Revictimized                   Non revictimized 
 
Figure 2. KIVS lifetime exposure in revictimized and non revictimized suicide attempters 
KIVS  
Lifetime 
exposure 
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4.1.2 Clinical characteristics and ratings of depressive symptoms, 
childhood adversity and hypersexuality in study IV of hypersexual 
disorder 
 
Characteristics of study participants are presented in Table 4.  
Table 4. Characteristics and clinical ratings of study participants in study IV-Hypersexual 
disorder 
 Patients Healthy Volunteers 
N=39 
Statistics (t-test, Kruskall 
Wallis), p value 
    
Age (years)                             Mean 
Range 
Std 
39.2 
19-65 
11.5 
37.5 
21-62 
11.9 
                   p=0.45 
HDSI                                         Mean 
                                                 Range 
                                                      Std 
19.6 
6-28 
5.7 
1.6 
0-9 
2.2 
p<0.001 
SCS                                           Mean 
Range 
Std 
27.8 
12-39 
6.9 
11.1 
10-14 
1.2 
p<0.001 
HD:CAS                                    Mean 
Range 
Std            
10.3 
1-22 
5.4 
0.38 
0-4 
0.88 
p<0.001 
MADRS                                    Mean 
Range 
Std 
18.9 
1-50 
9.7 
2.4 
0-12 
2.9 
p<0.001 
CTQ Total  (n=65)                  Mean  
   Range 
                            Std 
39.95 
25-80 
11.48 
32.53 
25-70 
8.75 
p<0.001 
CTQ Emotional Abuse           Mean 
Range 
Std 
8.1 
5-18 
3.1 
6.2 
5-16 
2,4 
p=0.0003 
CTQ Physical Abuse               Mean 
Range 
Std 
6.5 
5-19 
2.8 
5.4 
5-9 
1.1 
p=0.0084 
CTQ Sexual Abuse                 Mean 
Range 
Std 
5.8 
5-16 
2.1 
5.1 
5-7 
0.3 
p=0.0079 
CTQ Emotional Neglect        Mean 
Range 
Std 
12.0 
5-25 
4.5 
9.4 
5-24 
4.1 
p=0.0011 
CTQ Physical Neglect            Mean 
Range 
Std 
7.5 
5-17 
2.5 
6.4 
5-16 
2.5 
p=0.0017 
CTQ Minimization/Denial    Mean 
Range 
Std 
8.5 
3-15 
3.0 
10.6 
3-15 
2.7 
p=0.0004 
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The SCS scores showed a significant positive correlation with HD:CAS scores (rho = 0.5, p < 
0.0001).  
There was a significant positive correlation between depression severity measured with 
MADRS-S and ratings of hypersexual behavior (SCS, HD:CAS), ( p = 0.0026; p = 0.0036). 
There was also a significant positive correlation between HD:CAS and CTQ (rho=0.28, p = 
0.025). 
The correlations between CTQ with SCS and MADRS-S scores were not significant (p = 
0.76; p = 0.49). 
 
4.2  NEUROENDOCRINE MEASUREMENTS IN SUICIDE ATTEMPTERS 
4.2.1 CSF and plasma Oxytocin levels 
 
The mean CSF and plasma oxytocin levels are presented in Table 5.  
CSF oxytocin levels in suicide attempters showed a trend to be lower compared to healthy 
volunteers adjusted for age, (t ratio = -1.81, p = 0.077, Cohen’s d = 0.59, 95% CI = -0.03-
1.21), Figure 3. 
CSF and plasma oxytocin levels did not differ significantly between male and female 
suicide attempters (p = 0.38; p = 0.35) or between male and female healthy volunteers (p = 
0.57; p = 0.13). 
 
 
Table 5. CSF and plasma oxytocin levels in suicide attempters and healthy volunteers 
 
                                                            CSF Oxytocin (fmol/mL) 
 
 
 
 
 
                                                            Plasma Oxytocin (fmol/mL) 
 
 
 
 Mean Median SD Range 
All patients, (N=24) 11.7 11 3.9 6-22 
Healthy volunteers (N=18) 19.2 13 15.1 5-54 
 Mean Median SD Range 
All patients,(N=24) 6.2 5 3.2 2-15 
Healthy volunteers,  
(N=19) 
4.9 4 3.8 1-16 
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Figure 3. CSF oxytocin levels in suicide attempters and healthy volunteers 
 
 
4.2.2 CSF and plasma Cortisol and DHEAS levels  
 
CSF and plasma cortisol and DHEA-S levels in patients and in healthy volunteers as well 
as unadjusted and adjusted group comparisons are shown in Table 6.  CSF and plasma 
cortisol levels were higher in suicide attempters compared to healthy volunteers adjusted 
for age, major depression diagnosis and comorbid substance misuse diagnosis (t ratio=2.8, 
p=0.009; t ratio=2.8, p=0.007), Figure 4. 
CSF DHEA-S levels did not differ significantly between suicide attempters and healthy 
volunteers (t ratio=0.9, p=0.4). Broken down by gender, male suicide attempters had 
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significantly higher CSF DHEA-S levels compared to male healthy volunteers adjusted for 
age (t ratio=2.2, p=0.04). 
 A sensitivity analysis was performed due to the age difference between the groups by 
removing male patients within the age range not represented in controls. There was a 
significant difference in mean CSF DHEA-S levels between male patients (Mean±SD) 
(12.9±3.7 nmol/l, n=6) and male controls (8.4±2.6 nmol/l, n=12), p=0.009, Figure 5. 
CSF DHEA-S levels did not differ significantly between female suicide attempters 
(Mean±SD) (7.2±3.9 nmol/l, n=10) and female healthy volunteers (Mean±SD) (9.2±3.5 
nmol/l, n=6) (t ratio=-0.74, p=0.47, age adjusted). 
 
 
 
             
 
Figure 4. Plasma cortisol levels in suicide attempters and healthy volunteers 
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Table 6. CSF 5-HIAA, CSF and plasma cortisol and DHEAS levels (nmol/l) in suicide 
attempters and healthy volunteers 
 
 
a Univariate test methods one way Anova, Wilcoxon test. 
*Group comparison adjusted for age, comorbid substance abuse and diagnosis of major 
depression. All other comparisons adjusted for age. 
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Figure 5. CSF DHEAS levels in male suicide attempters and male healthy volunteers 
(sensitivity analysis) 
 
4.2.3 CSF 5-HIAA levels  
 
Suicide attempters tended to have lower CSF 5-HIAA levels compared to healthy volunteers 
adjusted for age (t ratio=-1.5, p=0.1). Broken down by gender only female suicide attempters 
had significantly lower CSF 5-HIAA levels compared to female healthy volunteers adjusted 
for age, comorbid depression diagnosis and substance abuse (t ratio=-3.2, p=0.009). 
CSF 5-HIAA showed a trend for correlation with CSF cortisol levels in suicide attempters 
(r=0.40, n=24, p=0.05) and a significant positive correlation with CSF cortisol/DHEAS ratio 
(rho=0.55, p=0.04) in male suicide attempters,  
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4.3 NEUROENDOCRINE MEASUREMENTS IN HYPERSEXUAL DISORDER  
 
4.3.1 Dexamethasone suppression test 
 
Baseline cortisol and ACTH levels did not differ between patients and healthy volunteers. 
The dexamethasone non-suppression status was significantly more common in patients with 
hypersexual disorder with 18 of 67 (26.9%) classified as non-suppressors whereas 4 of 39 
(10.3%) healthy volunteers were classified as non-suppressors (p = 0.049, Fisher’s exact test, 
two-tailed). There was no significant difference in age, use of antidepressants, or depression 
severity between non-suppressors and suppressors in patients with hypersexual disorder. 
DST Cortisol levels showed a trend to be higher in patients compared to healthy controls (p = 
0.096). A ROC analysis, estimated the optimal threshold level for the non-suppressor status 
of DST cortisol concentration at 8 a.m., for prediction of the diagnosis of hypersexual 
disorder, to be higher than (=5μg/dl), namely 7.3 μg/dl (sensitivity 19.4 %, specificity 100%, 
AUC = 0.60; Chi square DST cortisol = 4.92, p = 0.027). 
Patients with hypersexual disorder had significantly higher DST ACTH compared to healthy 
volunteers (p = 0.001), Figure 6. 
Models from regression analyses to determine whether DST non-suppression status could be 
predicted by the diagnosis of hypersexual disorder adjusted for childhood trauma and for 
frequency of hypersexual behavior during the last two weeks and whether plasma DST 
ACTH could be predicted by the diagnosis of hypersexual disorder adjusted for childhood 
trauma were significant, (Chi square = 11.83, p = 0.0080; adjusted RSq = 0.13, p = 0.0003). 
Tables 7 and 8.  
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Figure 6. Mean post-dexamethasone plasma ACTH concentrations in male patients with 
hypersexual disorder and in male healthy volunteers.*p-value = 0.0011. 
 
 
Table 7.  Logistic regression analysis of predictors to dexamethasone non suppression 
status in study participants 
 
 
 
 
 
Table 8. Regression analysis of correlates to post dexamethasone suppression test ACTH 
levels in men with hypersexual disorder. 
 
 t ratio p value 
Hypersexual disorder   3.74 0.0003 
Childhood trauma  
(CTQ) 
 -3.03 0.0031 
 
 
 chi square p value 
Hypersexual disorder  9.90 0.0016 
Childhood trauma  
(CTQ) 
 1.53 0.22 
HD:CAS  3.65 0.056 
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4.4 NEUROENDOCRINE MEASUREMENTS AND CLINICAL RATINGS 
 
4.4.1  CSF and plasma oxytocin and suicide intent 
 
Correlations between CSF oxytocin and the Suicide Intent Scale, Planning subscale and 
Freeman scales in suicide attempters broken down by gender are presented in Table 9 and 
Figure 7. 
 
 
 
 
Table 9. Correlations (Pearson’s r or Spearman’s ρ ) between CSF oxytocin and the Suicide 
Intent Scale, Planning subscale and Freeman scales in suicide attempters 
 
 
 
 Suicide Intent Planning 
subscale 
Freeman 
probability of 
intervention  
Freeman total  
CSF Oxytocin -0.37*  -0.48**  -0.40* -0.18 
 -0.87*** 
0.06 
-0.78*** 
-0.28 
-0.58** 
-0.15 
-0.23 
-0.05 
     
 
*** p<0.01 
**p<0.05 
* p<0.1 
Bold: all suicide attempters 
Men 
Women 
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Figure 7. Suicide intent (SIS score) and CSF Oxytocin in male suicide attempters 
Α regression model for predicting CSF oxytocin was significant (RSq adj = 0.52, DF = 4, n = 
20, p = 0.0042.), Table 10.   
Table 10. Regression analysis with suicide intent and violent behavior as predictors for CSF 
oxytocin levels in suicide attempters  
 t ratio p value 
Suicide Intent -3.33 0.0046 
KIVS lifetime violent behaviour  -1.79 0.094 
Age -0.36 0.72 
Gender (Woman)  2.68 0.017 
 
CSF Oxytocin did not correlate with plasma oxytocin significantly. Plasma oxytocin was 
significantly correlated with the planning subscale of SIS  in the whole group of suicide 
attempters and with both Freeman interruption probability and the planning subscale of SIS 
only in male suicide attempters when broken by gender (r =-0.44, p =0.048; r =-0.29, p = 
0.18; r = -0.58, p = 0.029). 
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4.4.2 HPA axis and hypersexual behavior 
 
Both the Sexual compulsivity scale scores and HD:CAS scores showed a significant negative 
correlation with baseline cortisol plasma levels (r = -0.25,p = 0.041; rho = -0.31, p = 0.012) 
HD:CAS scores correlated also negatively with DST cortisol ( rho = -0.33, p = 0.0071), 
Figure 8. 
 
 
Figure 8. Hypersexual behavior (HD:CAS) and DST cortisol levels in male patients with 
hypersexual disorder 
 
4.4.3 Childhood adversity-Revictimization, Depression and Neuroendocrine 
measurements  
 
Oxytocin- Cortisol and DHEAS in Suicide attempters 
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CSF and plasma oxytocin did not show a significant correlation with exposure scores to 
interpersonal violence as a child and as an adult (rho=0.16, p=0.49; rho=0.04, p=0.85), 
(rho=–0.23, p=0.31; rho=–0.30, p=0.18) 
Revictimized suicide attempters had significantly lower plasma oxytocin levels compared to 
non revictimized suicide attempters (p=0.046) whereas the CSF oxytocin levels did not differ 
significantly between the two groups (p=0.85), Figure 9. 
Exposure to interpersonal violence as a child showed a trend for negative correlation with 
CSF cortisol/DHEAS ratio (rho=-0.39, n=21, p=0.08).  Lower CSF cortisol/DHEAS ratio 
was associated with higher exposure to interpersonal violence as a child adjusted for age, 
gender and severity of depression in the regression model. 
Lifetime violent behavior showed a trend to negative correlation with CSF oxytocin (r =-
0.38, n = 22, p = 0.084). CSF oxytocin showed this trend for negative correlation with 
lifetime violent behavior only in women suicide attempters (r = -0.64, n = 9, p = 0.065). 
Depression severity measured with MADRS showed a trend for positive correlation with 
CSF cortisol (r=0.35, p=0.1) and a significant positive correlation with CSF cortisol only in 
male suicide attempters (r=0.69, p=0.009). 
 
Figure 9. Mean plasma oxytocin levels in revictimized and non-revictimized suicide 
attempters 
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Hypersexual disorder 
 
In the patients with hypersexual disorder, exposure to childhood trauma measured with CTQ 
showed a significant negative correlation with DST ACTH (rho = -0.28, p = 0.02) and a trend 
for negative correlation with DST Cortisol (rho = -0.21, p = 0.09), Figure 10.  
The correlations between all HPA axis measures and depression severity measured with 
MADRS were non-significant (p = 0.9; p = 0.7; p = 0.8; p = 0.7). 
 
 
Figure 10. Exposure to childhood trauma (CTQ) and DST ACTH in hypersexual disorder 
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4.5 COMPLETED SUICIDE  
 
There were six suicides (21.4%) during the follow-up time: 2 women and 4 men.  
SIS and KIVS scores did not differ significantly between suicides and survivors (p = 0.45; p 
= 0.53). 
Five of six suicide victims had CSF 5-HIAA level below the median (p=0.08, Fisher exact 
one sided).Four of five suicide victims had CSF cortisol level above the median (p=0.16, 
Fisher exact one sided). Figure 11. 
CSF cortisol was significantly higher in suicide victims with high exposure to interpersonal 
violence as a child (scores from 4 to 5) compared to suicide victims with low exposure to 
interpersonal violence as a child (scores from 0 to 2), (p=0.003). 
There was no significant difference in CSF and plasma oxytocin, CSF DHEA-S levels, and 
CSF cortisol/DHEAS ratio between suicides and survivors (p = 0.32; p = 0.49; p=0.47; 
p=0.9), Figure. 12 shows CSF oxytocin levels in suicide victims and survivors. 
 
             
 Figure 11. Correlation between CSF 5-HIAA and CSF cortisol with median split lines. 
Suicide victims marked with stars.  
  43 
       
             
 
  
 
Figure 12.  CSF oxytocin levels in suicide victims and survivors. 
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5 DISCUSSION 
 
5.1 THE ROLE OF OXYTOCIN IN SUICIDE ATTEMPTERS 
 
To begin with, although there was no significant difference in CSF and plasma oxytocin 
levels between suicide attempters and healthy volunteers, there was a trend for lower CSF 
levels in suicide attempters group compared to healthy volunteers. Moreover, both low CSF 
and plasma oxytocin were associated with a stronger intent to die in male suicide attempters. 
The activity of oxytocin in the brain is measured with CSF levels, that do not necessarily 
correlate with plasma levels as the dendritic and terminal secretion of oxytocin may not be 
always coordinated and depends on the stimulus (Altemus et al., 2004; Landgraf and 
Neumann, 2004). In our study, although CSF and plasma oxytocin levels did not show a 
correlation, they both negatively correlated with suicide intent. The inverse relationship 
between oxytocin and suicide intent was shown with two different rating scales measuring 
suicide intent. This negative correlation between oxytocin levels and suicide intent was more 
obvious with the planning subscale of the Suicide Intent Scale, reaching significance level in 
the whole group of suicide attempters. Only one study, Lee et al. investigated oxytocin’s 
relation in suicide behavior and reported lower levels of CSF oxytocin in four suicide 
attempters compared to 36 non-attempters with personality disorder (Lee et al., 2009).  
But what are the suicide intent scales measuring and how can their relationship with oxytocin 
be understood? The planning subscale of Beck Suicide Intent Scale includes the factual 
aspects and circumstances of suicide behavior such as the degree of premeditation and 
preparation for attempt, leaving a suicide note, the timing and isolation with precautions 
against intervention as well as acting to gain help during the attempt and the final acts in 
anticipation of death. Similarly, the Freeman interruption probability scale measures how 
likely is the event of rescue that depends directly on the circumstances of the suicide attempt, 
explicitly the degree of isolation.  
Known risk factors for suicide include lack of social support, isolation (Heikkinen et al., 
1994) and oxytocin has a key role in prosocial behavior, affiliative behavior and attachment 
(Heinrichs et al., 2009). Oxytocin is also important in processing social stimuli and social 
memory as well as social decision making in social contexts (Macdonald and Macdonald, 
2010). In the present cohort of suicide patients scored high in SIS with mean score almost 18. 
Although the predictive value of a rare event such as suicide is low, in a review on suicide 
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intent scale, the authors report a positive predictive value of 22.5% with a cut-off score of 19 
(Freedenthal, 2008). This indicates that this sample of suicide attempters had a serious intent 
to die rather than the suicide attempt being a way to get attention and help. The lower 
oxytocin in the suicide attempters might reflect a deficit in prosocial behavior leading to an 
impaired social support network that increases the risk for suicide behavior.  
Oxytocin might be related with suicide behavior in other ways.  It has been suggested that 
suicide attempters have ‘‘cognitive rigidity’’(Neuringer, 1964) as well as deficits in decision 
making when making choices under uncertainty (Jollant et al., 2010; Turecki and Brent, 
2015). Even healthy first degree relatives to suicide completers may exhibit impairment in 
decision making (Hoehne et al., 2015). Oxytocin is implicated in stress regulation, regulates 
stress in relation to social interaction and has an inhibitory effect on the HPA axis (Heinrichs 
et al., 2003; Neumann, 2009). In animal studies, intracerebral administration of oxytocin 
increases cognitive flexibility and the impaired social behavior in oxytocin receptor null mice 
(Sala et al., 2011). 
Yrigollen et al. reported that a number of genes associated with the oxytocin system and 
affiliative behavior are associated with autism spectrum disorders (Yrigollen et al., 2008) and 
Hollander et al., reported that infusions of oxytocin can reduce repetitive behavior in adults 
with autistic traits and Asperger syndrome (Hollander et al., 2003). Neumann et al., reported 
that oxytocin inhibits the stress-induced activity of the HPA axis responsiveness (Neumann, 
2002). Thus the oxytocin system might be related to suicide behavior through social factors 
as well as stress regulation and cognitive deficits such as in decision making. 
Although in the same direction, no significant correlation of suicide intent and oxytocin was 
observed in women. This lack of association might be due to confounding factors that were 
not taken into consideration, namely the effects of estrogen on oxytocin levels as a result of 
the normal variation of their menstrual cycle. It might also be that gender difference 
regarding the role of oxytocin make men more vulnerable to a possible dysfunction of the 
oxytocin system.  
Oxytocin is also related to aggression and is shown that mice with knockout of the oxytocin 
gene or receptor have more aggression and altered social behavior (DeVries et al., 1997; 
Ragnauth et al., 2005; Takayanagi et al., 2005; Winslow et al., 2000; Winslow et al., 2003). 
Moreover, exogenous intracerebral administration of oxytocin in oxytocin receptor null mice 
causes a reduction in their aggressive behavior (Sala et al., 2011). In humans, the 
administration of intranasal oxytocin regulates defensive aggression toward out-groups 
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among humans and increases in-group trust and cooperation among humans (De Dreu et al., 
2010). Oxytocin was also reported to reduce stress reactivity when administered to patients 
with borderline personality disorder (Simeon et al., 2011). However, the effects of oxytocin 
seem to depend on the context and underlying psychopathology. Bartz et al., reported that 
patients with borderline personality disorder with chronic interpersonal insecurities when 
administrated intranasal oxytocin showed less trust and less cooperative responses (Bartz et 
al., 2011).  
Lee et al., reported for the first time in humans that life history of aggression was negatively 
correlated with CSF oxytocin(Lee et al., 2009). In the same study, it was also first reported an 
inverse relationship between CSF Oxytocin levels and a history of suicidal behavior. In the 
same line, in the female suicide attempters, we reported a trend for negative correlation 
between CSF oxytocin and lifetime expressed violent behavior and in the regression analysis 
for predicting CSF oxytocin (corrected for age and gender) suicide intent was a significant 
predictor whereas lifetime expressed violent behavior remained at the trend level. 
As already been discussed, childhood trauma has an impact and long lasting effects on the 
different neurobiological systems (De Bellis and Zisk, 2014). We did not found the 
expected negative correlation between oxytocin levels and childhood trauma as it was 
previously reported in the literature (Bertsch et al., 2013; Heim et al., 2009; Opacka-Juffry 
and Mohiyeddini, 2012). As only large effects of the exposure to childhood trauma on 
oxytocin levels could be shown because of sample size limitations, these negative finding 
may be a type II error. There are also importance differences in the sample characteristics 
between different studies. Heim et al., as well as Opacka-Juffry and Mohiyeddini reported 
the inverse correlation in samples of volunteers while our sample consisted of suicide 
attempters with high levels of psychopathology including comorbidity.  Different 
instruments in measuring childhood trauma were used that may also account for this 
discrepancy as our measurement with KIVS does not focus on emotional abuse and neglect 
that has been strongly associated with oxytocin. 
Moreover, the revictimized group that had the highest sum of exposure to violence and 
trauma had lower levels of plasma oxytocin compared to non revictimized suicide 
attempters. Additionally, as childhood emotional climate scores were lower in the 
revictimized group and the revictimized were not more depressed than non revictimized, 
the revictimization status seems to be related more to childhood adversity than the present 
state. It might be so that the revictimized group had a major impact on the oxytocin system 
that we were able to detect and the subsequent dysfunction with lower oxytocin levels leads 
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to revictimization (Heim et al., 2009).  Being a victim of violence in childhood is associated 
with higher risk for revictimization in adult life (Widom et al., 2008).  This was also present 
in our group with reported positive correlations between exposure to violence as a child and 
exposure to violence in adulthood.   
However, not all studies report lower oxytocin in relation to childhood adversity. 
Pierrehumbert et al., reported higher levels of oxytocin in maltreated women and young 
girls (Pierrehumbert et al., 2010). Although there are contradicting results, there is 
consensus regarding the possible effect of both genetic and epigenetic factors on the 
oxytocin system (De Bellis and Zisk, 2014; Herpertz and Bertsch, 2015; Seltzer et al., 
2014). Genetic factors such as the oxytocin transporter rs2254298 polymorphism were 
reported to interact with early adversity and predict anxiety and depressive symptoms 
(Thompson et al., 2011). Cicchetti  et al., reported a three way interaction between 
maltreatment X gender X Genetic variants of the OXTR genotype in predicting borderline 
symptomatology (Cicchetti et al., 2014). Bradley et al., reported an interaction between the 
oxytocin receptor gene polymorphism OXTR rs53576 and a positive family environment in 
predicting resilient coping and positive affect (Bradley et al., 2013). Finally, Herpertz and 
Bertsch proposed a model for the pathophysiology of borderline personality disorder in 
which oxytocin has a central role affecting among others the social approach behavior and 
affect regulation (Herpertz and Bertsch, 2015). 
 
5.2 THE ROLE OF CORTISOL AND SEROTONIN 
 
Cortisol in both CSF and plasma was significantly higher in suicide attempters compared to 
healthy volunteers. This is in line with the literature suggesting a hyperactivity of the HPA 
axis often shown with DST non suppression. This is most commonly found in suicide 
victims with Coryell and Schlesser reporting that DST non suppression status increases the 
risk for suicide 14 times compared to suppressors (Coryell and Schlesser, 2001). In suicide 
attempters the hyperactivity of HPA axis is not that profound and literature has shown 
mixed results (Coryell, 2012). A recent meta-analysis of cortisol levels reported an age 
depended effect of cortisol with the association shown in younger patients (O'Connor et al., 
2016). Depression can be a confounding factor and in our sample depression severity 
tended to correlate with CSF cortisol levels and correlated significantly only in men. 
However, mood disorder diagnoses did not have effect on the results concerning the group 
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comparisons of CSF cortisol. The literature suggests a deregulation of HPA axis in 
depression with higher cortisol levels (Swaab et al., 2005). The deregulation is from an 
overactive HPA axis with increased ACTH secretion and hypercortisolemia, especially in 
depression with melancholic and psychotic features (Carroll et al., 2007; Mann and Currier, 
2007).   
Only female suicide attempters had lower CSF 5-HIAA levels compared to female healthy 
volunteers. Low 5-HIAA in the CSF is the most replicated biomarker for suicide (Rosell and 
Siever, 2015; Turecki, 2014) but mostly reported in men. The question of trait or state of the 
low 5-HIAA in suicide has been ongoing (Asberg et al., 1986). Serotonin dysfunction has 
been related to both traits of anxiety, impulsivity and aggression and at the same time to 
depression (Mann and Currier, 2007). 
 
5.3 THE ROLE OF DHEA-S IN SUICIDE ATTEMPTERS 
 
There was no significant difference between CSF and plasma DHEA-S levels in the whole 
group of suicide attempters compared to healthy volunteers. When gender and age taken into 
account, as DHEA-S levels are declining with increasing age, we found that only male 
suicide attempters had higher CSF DHEA-S levels compared to male healthy volunteers. This 
finding is not related with depression severity or comorbidity with mood disorder and 
substance abuse. Additionally, the most common finding in depression is decreased DHEA-S 
(Maninger et al., 2009). DHEA-S has not been investigated in suicide and only one study in 
male veterans with PTSD reported increased DHEA plasma levels in the veterans with a 
previous suicide attempt compared with those without a history of suicide attempt 
(Butterfield et al., 2005). How can the higher DHEA-S levels interpreted in suicide?  
The higher DHEA-S levels can be understood as an adaptive and compensatory mechanism 
as an effect of childhood adversity. DHEA-S is implicated in stress regulation and the ratio 
with cortisol (cortisol/DHEA-S) in the estimation of the allostatic load (Maninger et al., 
2009). This ratio is proposed as a sensitive measure of the allostatic load.  The role of DHEA-
S is suggested to be protective, promoting resilience in stress and childhood trauma (Yehuda 
and Flory, 2007). DHEA-S has been shown to promote coping even in experimental stress 
conditions (Morgan et al., 2009; Morgan et al., 2004). 
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Indeed, higher exposure to interpersonal violence as a child adjusted for age, gender and 
severity of depression was related with lower CSF cortisol/DHEA-S ratio in suicide 
attempters.  Other studies also found lower plasma cortisol/DHEA-S ratio in PTSD patients 
with a history of childhood abuse (Kellner et al., 2010; Yehuda et al., 2006). Low cortisol 
levels are usually found in adults that were exposed to childhood adversity (Heim et al., 
2001), together with high DHEA-S levels as compensation, can stand for the low ratio in 
suicide attempters exposed to childhood trauma. 
An alternative explanation of the higher levels of DHEA-S can be found in aggressive and 
violent behavior that is a known risk factor for suicide (Jokinen et al., 2010).  Although the 
role of DHEA-S is not clear yet in aggression there is some preliminary findings such as the 
fact that higher DHEA-S levels were reported in male adolescents with conduct disorder 
(Maninger et al., 2009; van Goozen et al., 1998). Furthermore, congenital adrenal 
hyperplasia, prenatal androgen exposure of the brain alters personality characteristics of 
aggression in a gender specific manner (Mathews et al., 2009). 
Although, the exact actions of DHEA-S are yet to be revealed, DHEA-S increases 
neurogenesis via brain-derived neurotrophic factor (BDNF), is a non-competitive antagonist 
on the GABAA receptors and acts on NMDA and sigma-1 receptors (Maninger et al., 2009). 
 
5.4 SUICIDE RISK AND PREDICTION 
 
From the 28 suicide attempters, 6 (21.4%) died from a subsequent suicide during the mean 
follow up time of more than 20 years. This indicates that this was a clinical sample of very 
high suicide risk equivalent to the risk suicide attempters with severe coexistent psychiatric 
disorder (Tidemalm et al., 2008). 
We confirmed previous findings of the hyperactivity HPA axis and suicide risk as four of five 
suicide victims had CSF cortisol level above the median (Jokinen et al., 2007). Specifically, 
suicide victims with high exposure to interpersonal violence as a child had higher CSF 
cortisol levels compared to suicide victims with low exposure.  
This is in line with previous research on gene X environment interaction. Although the results 
from environment gene interaction studies have not been consistent, mainly due to 
methodological issues, there are some promising results by revealing specific interactions 
(Mandelli and Serretti, 2013).  Roy et al. found an interaction effect increasing the risk for 
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suicide attempt, between exposure to childhood adversity and the FKBP5, a gene related to 
stress by moderating the activation of the glucocorticoid receptor (Roy et al., 2010). In the 
same line, Guillaume et al. reported an environment (childhood adversity in the form of 
sexual abuse and emotional neglect) X gene (CRH receptors gene) interaction on decision-
making in suicide attempters (Guillaume et al., 2013). But beyond the genetic control of the 
FKBP5 gene, Zannas et al., proposes also epigenetic regulation of glucocorticoid-responsive 
genomic sites leading to FKBP5 disinhibition and stress related disorders (Zannas et al., 
2016). 
Results on epigenetic regulation have been already reported. Mc Gowan et al., in a post 
mortem study found epigenetic changes, increased methylation in a neuron-specific 
glucocorticoid receptor (NR3C1) promoter and lower levels of hippocampal glucocorticoid 
receptor expression in suicide victims with a history of childhood abuse compared to suicide 
victims without a history of child abuse (McGowan et al., 2009). Additionally, Labonte et al., 
reported site-specific DNA methylation alterations at the hippocampal glucocorticoid 
receptor promoter in abused suicide victims supporting that childhood adversity induces long 
lasting effects (Labonte et al., 2012). Moreover, in a study investigating DNA methylation 
levels genome-wide, reported that increased methylation of the Kit ligand gene was a 
mediator of the effect of childhood trauma resulting in lower cortisol reactivity in healthy 
individuals who underwent the Trier Social Stress Test (Houtepen et al., 2016). 
Regarding the serotonin system, its main metabolite 5-HIAA in CSF was below the median 
in five out of six suicide victims. This is well documented finding in the literature that 
confirms the deregulation of the serotonins system in suicide. CSF 5-HIAA has been 
suggested as a suicide risk factor in the short term together with DST non suppression in the 
long term (Jokinen et al., 2009; Nordstrom et al., 1994; Samuelsson et al., 2006). Neither 
oxytocin nor DHEA-S was associated with completed suicide.   
It is important to notice that there were correlations between the neuroendocrine biomarkers. 
CSF 5-HIAA showed a trend for positive correlation with CSF cortisol in suicide attempters 
and correlated positively with CSF cortisol/DHEAS ratio in male suicide attempters. Previous 
research suggests that although the serotonergic system and HPA axis interact and are 
influenced by genetic and epigenetic factors they are considered as independent predictors of 
suicide behavior (Jokinen et al., 2008; Jokinen et al., 2009). A bidirectional interaction is also 
proposed between the serotonergic system and DHEA-S through modulation of the CRH and 
ACTH release by hypothalamic 5-HT1A receptor and GABAA receptor-mediated regulation 
(Gartside et al., 2010; Moser et al., 2010). 
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The current predictive models for suicide are not effective in clinical praxis and the 
“biosignature for suicide” remains to be found (Oquendo et al., 2014). New biological 
pathways and research methodologies are applied and Sokolowski et al., proposed suicide 
behavior as one meta-system based on physical protein interaction, the interactome 
addressing the neurobiology of suicidal behavior as system imbalances (Sokolowski et al., 
2015). The combination of both genetic as well as clinical assessments has shown promising 
results in the prediction of suicidal behavior (Niculescu et al., 2015). 
 
5.5 HPA AXIS IN HYPERSEXUAL DISORDER 
 
This thesis includes the first study investigating the HPA axis in male patients with 
hypersexual disorder reporting a dysregulation of the HPA axis shown with significantly 
more prevalent DST non-suppression status and higher DST ACTH plasma levels compared 
to healthy controls. These results were neither an effect of depressive symptoms nor 
childhood adversity suggesting a hyperactive HPA axis in male patients with hypersexual 
disorder and DST non-suppression status was predicted by the diagnosis of hypersexual 
disorder even when adjusted for childhood trauma and for hypersexual behavior during the 
last two weeks. 
A hyperactive HPA axis in hypersexual disorder could be understood from the addiction 
model perspective. The definition of hypersexual disorder includes aspects of addiction such 
as that the person is “ repetitively engaging in sexual fantasies, urges or behaviors in response 
to dysphoric mood states” such as anxiety and depression that may well correspond to 
craving and that there are “repetitive but unsuccessful efforts to control or significantly 
reduce these sexual fantasies, urges or behaviors” as well as “repetitively engaging in sexual 
behaviors while disregarding the risk for physical or emotional harm to self or others” 
(Kafka, 2010). According to the addiction model, the chronic use of substances induces 
increased levels of ACTH, thus a hyperactive HPA axis, with the corticotropin-releasing 
factor (CRF) facilitating craving by increasing negative affects during drug withdrawal. Thus, 
craving is a response to the allostatic load (Kakko et al., 2008; Koob et al., 2014). Likewise, 
in hypersexual disorder, patients with a hyperactive HPA axis and increased ACTH maintain 
their “addictive” sexual behavior to avoid the negative affective state that occurs with 
withdrawal. Supporting the addiction model, a recent fMRI study in individuals with 
problematic hypersexual behavior reported significantly increased sexual desire as well as 
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changed activation in the prefrontal cortex and subcortical areas compared to controls 
suggesting an altered neural circuitry mediating cue-induced desire for sexual behavior 
analogous to substance and behavioral addiction (Seok and Sohn, 2015).  
Additionally, ratings of recent hypersexual severity (HD:CAS) showed a significant negative 
correlation with DST cortisol levels and both hypersexual rating scores (SCS, HD:CAS) were 
inversely related to  baseline cortisol plasma levels. The interpretations of results becomes 
difficult as the effect of stress and HPA axis on sexual behavior is not well understood with 
contradicting results (Goldey and van Anders, 2012). In some studies of healthy volunteers 
plasma cortisol levels did not change during sexual arousal and orgasm (Exton et al., 2001; 
Exton et al., 2000) while in others cortisol was positively related to sexual arousal (Goldey 
and van Anders, 2012). When investigating individuals with risky sexual behavior, Harrison 
et al., reported higher salivary cortisol reactivity to the imagined social situation exercise and 
proposed that childhood adversity might have been related to the results as they could not 
control for it (Harrison et al., 2014). 
In our study, patients scored higher in childhood trauma than healthy controls and in the same 
levels with other male clinical samples in Sweden (Gerdner and Allgulander, 2009). An 
inverse correlation between childhood trauma scores and DST ACTH was also reported. 
Being hyper suppressor of cortisol and ACTH after the DST was also reported in women 
with depression and a history of abuse in childhood (Newport et al., 2004). Contrary, Heim et 
al., reported increased cortisol and ACTH levels in the dexamethasone/CRF test in depressed 
men with childhood abuse compared to healthy controls as well as depressed men without a 
history of childhood abuse (Heim et al., 2008a). Differences in the degree of traumatization 
might account for this difference and the effects of childhood trauma on neurobiological 
systems with genetic and epigenetic regulation that have already been discussed, apply in this 
case also. Childhood adversity was positively related with the severity of hypersexual 
symptoms (HD:CAS). This is in the same line with studies reporting childhood adversity and 
especially sexual abuse as a risk factor for developing risky sexual behavior and sexual 
hyperactivity (Aaron, 2012; Wilson and Widom, 2008).  
The hypersexual patients had also more depressive symptoms but did not have an effect on 
the HPA axis, as already mentioned, it is depression with melancholic and psychotic features 
that usually affects the HPA axis (Mann and Currier, 2007). 
Hypersexual behavior scores (SCS, HD:CAS) were positively related to depression scores 
(MADRS-S)  and in line with previous studies reporting positive correlation between 
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depressive symptoms and hypersexual behavior (Schultz et al., 2014). Hypersexual behavior 
is considered a response to dysphoric emotional states including anxiety and depressive 
symptoms (Kafka, 2010). 
 
Strengths and limitations 
 
The major strengths of the studies on suicide attempters (I-III) is the unique sample of suicide 
attempters with  simultaneous measurement of different neuroendocrine biomarkers in both 
CSF and plasma such as cortisol, oxytocin, DHEA-S and 5-HIAA. The suicide attempters 
group was well characterized with structured diagnostics and evaluation of multiple 
psychometric scales such as MADRS for depression severity and the assessment of the 
suicide intent with two different clinical ratings. The assessment of exposure to interpersonal 
violence was both in childhood and in adulthood thus assessing revictimization status. These 
data together with the long follow up through the death registry, of more than 20 years, make 
this material extremely valuable.    
The limitations should also mentioned, mainly the small sample size that is a limitation for 
generalizing the results as well as the lack of an age matched group of healthy volunteers. 
Due to the small sample size of the suicide attempters cohort (n=28) the question of statistical 
power to detect group differences arises. Therefore, false negative results that may occur may 
be from the lack of power to detect differences at the statistically significant level rather than 
being true negative results. Keeping that in mind, negative results were interpreted with extra 
caution.  
Additionally, the small sample is a limitation to use corrective analyses for multiple testing 
such as the Bonferroni to counteract possible false positive results. The risk would be great to 
dismiss false negative results as they would not reach the statistical level after applying 
Bonferroni correction analysis. In order to minimize these problems, all the analyses 
performed were hypothesis driven based on the literature and not exploratory analyses. It is 
also important to mention that the cohort of suicide attempters is a unique, rare sample of 
well characterized patients with CSF sampling that is very difficult to collect.  
Another issue is the mismatch regarding age between suicide attempters and healthy 
volunteers. As neuroendocrine measurements are affected by age efforts were made to adjust 
for age in the analyses and when necessary sensitivity analyses were performed to verify 
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some results. Especially, the number of females was very small and no information was 
acquired regarding their menstrual cycle or use of hormonal preparations. Additionally, due 
to some missing data in some measurements the sample size was smaller.  
The strengths of the study on hypersexual disorder (study IV) are the well characterized 
group of male patients with hypersexual disorder, the presence of an aged matched control 
group of healthy volunteers both with a structured interview and the use of rating scales that 
enabled us to control for possible confounders such as childhood adversity and depressive 
symptoms. The limitations include the self-report of childhood adversity, not controlling for 
dexamethasone plasma levels at the DST and as this is the first study reporting HPA axis 
deregulation in males with hypersexual disorder, the results needs replication in independent 
samples. 
Although there was a follow up of the suicide attempters the assessment of neuroendocrine 
biomarkers was in a cross-sectional design as in hypersexual disorder and this prevents us 
from drawing casual conclusions.  
 
6 CONCLUSIONS  
 
In conclusion, this thesis is a compilation of neuroendocrine studies in suicide attempters and 
in hypersexual disorder. Focus was on oxytocin, DHEA-S and the HPA axis as well as 
aspects such as suicide intent, lifetime violent behavior, exposure to childhood trauma and 
revictimization. Suicide attempters showed a trend for lower CSF oxytocin levels compared 
to healthy volunteers, CSF oxytocin was significantly negatively related to suicide intent 
and showed a trend for negative correlation with lifetime violent behavior. Revictimized 
suicide attempters had lower plasma oxytocin and more negative childhood emotional 
climate compared to non revictimized suicide attempters. Violence, trauma and suicide 
intent are risk factors for suicide and oxytocin by modulating prosocial behaviors might 
thus be protective in individuals with high suicide risk. 
Higher CSF and plasma cortisol levels were also present in suicide attempters compared to 
healthy volunteers, whereas CSF DHEA-S levels were higher in male suicide attempters 
and CSF 5-HIAA levels lower in female suicide attempters respectively. The role of 
DHEA-S in suicidal behavior is proposed to be through the effects of childhood trauma and 
its implication to the allostatic load while other possible mechanisms cannot be excluded.  
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In suicide prediction, suicide victims tended to have low CSF 5-HIAA and high CSF 
cortisol and suicide victims that were abused in childhood had higher CSF cortisol 
compared to suicide victims with low exposure to interpersonal violence as a child. 
The first study investigating HPA axis in hypersexual disorder shows hyperactivity with 
non-suppression after the dexamethasone suppression test and higher DST ACTH in male 
patients with hypersexual disorder compared to controls. Early life adversity, more 
prevalent in men with hypersexual disorder, was also related to HPA axis measures. 
However, diagnosis of hypersexual disorder was independently associated with hyperactive 
HPA axis, which fits well in neurobiology of addiction models. 
The results underlie the important role of biological systems such as the serotonergic 
system and HPA axis in the neurobiology of suicide and the preliminary results on oxytocin 
and DHEA-S calls for further investigation. The effect of childhood trauma on biological 
systems should be further studied in well-defined clinical settings and taken into 
consideration when investigating neurobiological systems. Finally, there is an increasing 
need for both biomarkers and prevention in both suicide and hypersexual disorder and 
childhood trauma and adversity is a possible target for prevention. 
 
7 FUTURE DIRECTIONS 
 
This thesis includes neuroendocrine studies in suicide attempters and in hypersexual disorder. 
The preliminary results on Oxytocin and DHEA-S are promising and these systems should be 
investigated also in hypersexual disorder. We have already approval from Regional Ethical 
Review Board in Stockholm (Dnrs:2013/1335-31/2) to conduct a broader study in 
hypersexual disorder including analysis of DHEA-S, testosterone and Oxytocin. Genetic as 
well as epigenetic analyses are planned in the near future. There is also an ongoing treatment 
study with cognitive behavioral therapy for patients with hypersexual disorder. Assessments 
of possible neuroendocrine biomarkers as well as dexamethasone suppression test was 
performed before and after the intervention and the results remain to be analyzed. Regarding 
suicide attempters, genetic as well as epigenetic analyses will be conducted. These studies in 
hypersexual disorder and suicidal behavior have the potential to contribute significantly to the 
development of new knowledge that might lead to clinical implications.  
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